- Acute ocular pain, stemming from conditions such as corneal abrasions, infections, and inflammatory disorders, is a growing concern globally, prompting heightened demand for effective analgesic therapies and rapid diagnosis
- The rising prevalence of eye strain due to increased screen time, along with expanding aging populations, significantly contributes to the growth of the Acute Ocular Pain market across both developed and developing nations
- North America dominated the acute ocular pain market with the largest revenue share of 38.7% in 2024, supported by strong healthcare infrastructure, higher awareness, and widespread access to prescription ophthalmic medications and diagnostics
- Asia-Pacific is expected to be the fastest growing region in the acute ocular pain market during the forecast period, with a projected CAGR of 7.9%, driven by rapid urbanization, increasing eye disease burden, and improved access to eye care in emerging economies such as India and China
- The topical NSAIDs segment dominates the acute ocular pain market with a market share of 45.6%, attributed to their efficacy in pain reduction, widespread usage, and strong physician preference in treating inflammation-related eye pain
